Drug Shortage Report for 0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION

Last updated on 2020-01-28 History
Report ID 101629
Drug Identification Number 00828602
Brand name LIDOCAINE HCL 0.4% AND 5% DEXTROSE INJ
Common or Proper name LIDOCAINE HCL 0.4% AND 5% DEXTROSE INJ
Company Name BAXTER CORPORATION
Market Status MARKETED
Active Ingredient(s) DEXTROSE LIDOCAINE HYDROCHLORIDE
Strength(s) 50MG 4MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 24 units/case
ATC code C01BB
ATC description ANTIARRHYTHMICS, CLASS I AND III
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-12-18
Actual start date 2019-12-18
Estimated end date 2020-01-27
Actual end date 2020-01-27
Shortage status Resolved
Updated date 2020-01-28
Company comments Baxter product LIDOCAINE HYDROCHLORIDE 0.4% AND 5% DEXTROSE INJECTION (250 mL bags) is available as a substitute.
Health Canada comments
Tier 3 Status No
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-01-28 English Compare
v4 2020-01-27 French Compare
v3 2020-01-27 English Compare
v2 2019-12-19 French Compare
v1 2019-12-19 English Compare

Showing 1 to 5 of 5